Save time and money in early development with Quotient Sciences

How does Translational Pharmaceutics® disrupt drug development?
John McDermott, VP of Scientific Consulting, explains how Translational Pharmaceutics® is different from traditional drug development strategies.
Let's talk about your drug program

Achieve your molecule’s full potential with our extensive experience in drug development, manufacturing & clinical testing

Partnering with an experienced pharmaceutical CDMO with the expertise, infrastructure, and agility needed to move your novel therapy forward, faster.

Let's discuss your next program and how we can help you:

  • Maximize Efficiency

Our teams utilize a range of drug development technologies in the most efficient way possible, applying our expertise to your molecule.

  • Bridge the Gaps

We help bridge the gaps that cause extra time ("white space") in the development process through close integration between drug product manufacturing and clinical testing.

  • Stay in Control

Our goal is to keep you on-course as you progress from your first in human trials, to optimizing drug product to support Phase Ib/IIa clinical studies, and conducting efficient human ADME studies.